McPherson's Limited · ASX:MCP
McPherson's — FY2017 Earnings Presentation
32 slides from McPherson's's earnings presentation, Aug 23, 2017
Slide 1: Full Year Results Release FY17
MCPHERSOWN S Est. 1:6:6.0 Full Year Results Release FY17 23 August 2017 Laurence McAllister Paul Witheridge Managing Director Chief Financial Officer
Slide 2: 2
2
Slide 3: 3
3
Slide 4: Financial Update
DRLEWI (TERNAL YOUTH
Slide 5: 5
5
Slide 6: FY17 financial results summary
Closure of Impulse Merchandising Division Revenue from continuing operations $279.5m 10.6% Reduction in low margin private label and agency sales Improved contribution margins Earnings before interest and tax $24.0m 0.5% Reduced selling and distribution costs Adverse AUD/USD currency impact Sign
Slide 7: Profit before tax bridge FY16 to FY17
Reduction in cooperative 0.2 advertising Various Others FX Impact costs 2.5 Reduction in 1.4 Reduction in selling and borrowing distribution (6.4) 2.6 costs costs $19.6m $17.1 Improvement 3.0 in contribution (0.8) margins Reduction in Home Appliances EBIT i) Demise of significant customer ii) Commer
Slide 8: Significant Items
Significant Items A$m FY2017 FY2016 Impairment of Home Appliances intangibles (12.0) - Impairment of Revitanail brand (6.9) - Impairment of New Zealand business segment (2.7) - Restructure costs (1.6) (5.8) Bond buy back costs (1.2) (0.2) Profit on divestment of IMD Singapore 0.2 - Gain on Sale of H
Slide 9: Operating cash flow, net debt and gearing
$30.8m operating cash flow before Underlying Cash Conversion* 113% interest and tax payments Strong operating cashflow Net Debt $36.4m 27.0% Improved working capital efficiency Gearing 29.2% 3.1pp Strong financial platform ROFE ** 15.4% 0.6pp Solid return on funds employed Normalised EBIT Inte
Slide 10: Operational Update
Operational Update
Slide 11: 11
11
Slide 12: Health Wellness Beauty
HEALTH WELLNESS BEAUTY HAPL 22% H,W& B Net Sales 61% Agency Contribution 17% 12 Source: Industry Revenue Complimentary Medicines Australia 2015 (2017 Est), Cosmetics/Toiletry retailing IBISWorld 2017 Est
Slide 13: China seeking high quality AU and NZ H,W & B brands
Traditional Focus beyond High Aging Channels dispensing to Growth Population sales flat front of shop over 4 years China seeking high quality AU and NZ H,W & B Brands 13
Slide 14: Industry revenue and growth for health and beauty
H&W $4.6 Bill +15% >66% 1.3 Mill Australians use Est. Industry revenue People add CM to CAGR complimentary 2017-18 existing treatments medicine(CM)) Beauty $4.0 Bill +3.2% Est. Industry revenue CAGR 2017-18 14
Slide 15: Brand Portfolio & Re-Investment Priorities
Brand Portfolio & Re-Investment Priorities DR:WOLFF ee BEAUTY DRLEWINNS' Maa [ Akin] LADY JAYNE’ I ¢ RRevitanalt: o y ass deh . GS EYLURE Qa goodness Investment Priorities DRLEWINNS: [Akin] Pmoricre f 15
Slide 16: Complementary medicines category value and growth
200 Bubble Size = Category Value 180 Mn AUD Avg. = 0.03% 160 Nutritional Oils Bone Health 140 Multi Vitamins Value MAT Mar’2017 120 Arthritis (Mn AUD) 100 Intestinal Health Pregnancy 80 Cold & Flu Relief 60 Muscular Support Cystitis Relief Iron Deficiency Sinus & Hayfever Heart Health 40 Skin Health
Slide 17: Refreshing the visual identity and packaging of brands
Executing on strategy by refreshing the visual identity and packaging of our brands PRLEWINNS - 2 - swisspers kicl as oa : oes S. & } RLEWINNS' [kin] | oiewf Ty DRLEWININS' 17
Slide 18: Increased commercial focus with our big 6 customers
• Increased commercial focus and execution capabilities with our “big 6” customers • Driving mutual growth through joint business planning 100 80 Priceline CWH 60 • Pharmacy channel sales more than Ind PHY doubled in the past six years 40 20 0 FY 11 FY 12 FY 13 FY 14 FY 15 FY16 FY 17 18
Slide 19: Karen Murrell and Dr Wolff partnerships
Karen Murrell – All Natural Lipsticks partnership • Domestic and export strategic partnership • Bundling opportunities with other brands • Potential to add margin that can be recycled into other brands Dr Wolff – European Alliance partnership • All products have a unique brand positioning and strong
Slide 20: Kingsgrove DC Facility
• Kingsgrove DC Facility is a significant enabler to reinvest in McPherson’s brands • Delivered significant efficiencies to free up supply chain capacity • Next steps will be about building on the platform for the future; Strategy , Planning & Sales & Key Account Export Research & Development Innova
Slide 21: Driving A'kin in the UK and EU and China
• Specialise in natural, good value – mid tier skincare and health brands • Working together to drive A’kin in the UK and EU • 5 star Tmall TP store operator • Secured the opening of Akin’s Official Tmall • A’kin has been positioned as a store. straightforward and simple • Targeted purchases of $1m
Slide 22: Outlook
a — & Outlook Te © NOURISHING CREAM CLEANSER & TONER With Rose, Geranium and Shea Butter to deep Kleanse and Witeh Haze! to balance and tone skit HYDRATING MIST TONER ganic Coconut Water and Green Tea efcesh, hydrate and tone skin TALL skin TyPes ] © 150mU/5.0.F1.0Z.US [ORY & SENSITIVE SKIN] © 150mU
Slide 23: McPherson's, a journey of profitable growth
‘McPherson’s, a journey of profitable growth…’ 23
Slide 24: Appendix
Appendix
Slide 25: Management team
Laurence Paul David Smith Brett Owers Sarah Tully Lori Pirozzi Byron Stone McAllister Witheridge Business New Business HR Director National Field Sales Managing CFO Development Commercial Accounts & Director Director Director Finance Export Director Director Donna Mary Mark Brady David Sammy John Re
Slide 26: Income statement summary
Sales 279.5 312.6 10.6% decrease in Sales Cost of Goods Sold 160.1 179.5 Gross Contribution 119.4 133.1 Expenses 92.1 106.4 13.4% decrease in Expenses EBITDA 27.3 26.7 2.2% increase in EBITDA Depreciation & amortisation (3.3) (2.8) EBIT 24.0 23.9 0.5% increase in EBIT Interest (4.4) (6.8) Interest c
Slide 27: NPBT reconciliation to statutory
NPBT excluding non-recurring items 19.6 17.1 Non-recurring items: - Impairment of intangibles (21.6) - - Restructuring costs (1.6) (5.8) - Bond buy back costs (1.3) (0.2) - 49% share of Housewares JV profit* - 1.8 - Gain on Sale of Housewares JV - 2.0 - Other non-recurring items 0.2 (0.3) Statutory
Slide 28: Cash flows from operations
Cash flows from operations Receipts from customers (inclusive of GST) 312.3 354.7 Payments to suppliers and employees (inclusive of GST) (281.5) (320.5) Net cash inflows from operations before interest and tax 30.8 34.2 Net interest and borrowing costs paid (5.2) (6.3) Income tax paid (1.4) (3.0) Ne
Slide 29: Cash flows from investing and financing activities
Cash flows from investing activities Payments for acquisition of business assets - (8.5) Payments for purchase of property, plant and equipment (1.6) (2.9) Payments for purchase of intangibles (0.3) (1.0) Proceeds from sale of business assets 0.5 18.3 Net cash outflows from investing activities (1.4
Slide 30: Funds employed and balance sheet summary
Inventories 59.3 59.8 Receivables 40.2 44.8 Payables (48.6) (48.8) Net working capital 50.9 55.8 Property, plant & equipment 4.9 5.8 Intangibles 93.0 115.1 Provisions & other net liabilities (13.5) (15.3) Total funds employed 135.3 161.4 Net financial debt (36.4) (50.0) Net tax balances (10.4) (7.0)
Slide 31: Top shareholders
Rank Investor Holding (shares) Holding (%) Cumulative (%) 1 Investors Mutual 9,800,000 9.4 9.4 2 Microequities 7,525,667 7.2 16.6 3 Dimensional Fund Advisors 5,125,548 4.9 21.5 4 Mr Paul J Maguire 2,433,143 2.3 23.8 5 Adam Smith Asset Mgt 2,229,201 2.1 25.9 6 TBF Investment Mgt 1,914,246 1.8 27.7 7
Slide 32: Non-IFRS measures and Disclaimer
Non-IFRS measures The non-IFRS measures used by the Company are relevant because they are consistent with measures used internally by management to assess the operating performance of the business. The non-IFRS measures have not been subject to audit or review. Disclaimer Statements contained in thi